Literature DB >> 30157480

Urinary Urgency in the Elderly.

Jeannette M Potts, Christopher K Payne.   

Abstract

The last 2 decades have brought an explosion of research, new products, and general attention to the problem of urinary urgency, and yet patients continue to be plagued by this symptom - especially the elderly. What is it? What does it mean? How can we guide patients successfully through this challenge? This paper presents a review of current thinking about urgency relevant to the practicing clinician, including the epidemiology, pathophysiology, evaluation, and treatment of these patients.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Elderly; Epidemiology; Pathophysiology; Treatment; Urinary urgency

Mesh:

Year:  2018        PMID: 30157480     DOI: 10.1159/000492330

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  4 in total

1.  Validity of the Central Sensitization Inventory (CSI) through Rasch analysis in patients with knee osteoarthritis.

Authors:  Naym U Roby; Tara L Packham; Joy C MacDermid; Lisa C Carlesso
Journal:  Clin Rheumatol       Date:  2022-06-27       Impact factor: 3.650

2.  Transcutaneous tibial nerve stimulation versus parasacral stimulation in the treatment of overactive bladder in elderly people: a triple-blinded randomized controlled trial.

Authors:  Raquel Henriques Jacomo; Aline Teixeira Alves; Adélia Lucio; Patrícia Azevedo Garcia; Dayanne Cristina Ramos Lorena; João Batista de Sousa
Journal:  Clinics (Sao Paulo)       Date:  2020-01-10       Impact factor: 2.365

3.  Diagnostic Potential of Low Serum Platelet, Albumin and Prolong PT-INR for Overactive Bladder and Nocturia in Chronic Hepatitis-Related Liver Cirrhosis.

Authors:  Po-Heng Chuang; Yi-Huei Chang; Po-Jen Hsiao; Eric Chieh-Lung Chou
Journal:  J Clin Med       Date:  2021-06-27       Impact factor: 4.241

4.  Cardiovascular safety of vibegron, a new β3-adrenoceptor agonist, in older patients with overactive bladder: Post-hoc analysis of a randomized, placebo-controlled, double-blind comparative phase 3 study.

Authors:  Masaki Yoshida; Masayuki Takeda; Momokazu Gotoh; Osamu Yokoyama; Hidehiro Kakizaki; Satoru Takahashi; Naoya Masumori; Shinji Nagai; Kazuyoshi Minemura
Journal:  Neurourol Urodyn       Date:  2021-06-17       Impact factor: 2.696

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.